507 related articles for article (PubMed ID: 18243101)
1. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.
LaPorte SL; Juo ZS; Vaclavikova J; Colf LA; Qi X; Heller NM; Keegan AD; Garcia KC
Cell; 2008 Jan; 132(2):259-72. PubMed ID: 18243101
[TBL] [Abstract][Full Text] [Related]
2. A new look at cytokine signaling.
Zdanov A; Wlodawer A
Cell; 2008 Jan; 132(2):179-81. PubMed ID: 18243092
[TBL] [Abstract][Full Text] [Related]
3. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
Andrews AL; Holloway JW; Holgate ST; Davies DE
J Immunol; 2006 Jun; 176(12):7456-61. PubMed ID: 16751391
[TBL] [Abstract][Full Text] [Related]
4. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Vazquez N; Davies KV; Finlay-Jones JJ; Donnelly RP
Eur J Immunol; 1999 Jul; 29(7):2087-97. PubMed ID: 10427971
[TBL] [Abstract][Full Text] [Related]
5. Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency.
Moraga I; Richter D; Wilmes S; Winkelmann H; Jude K; Thomas C; Suhoski MM; Engleman EG; Piehler J; Garcia KC
Sci Signal; 2015 Nov; 8(402):ra114. PubMed ID: 26554818
[TBL] [Abstract][Full Text] [Related]
6. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation.
Umeshita-Suyama R; Sugimoto R; Akaiwa M; Arima K; Yu B; Wada M; Kuwano M; Nakajima K; Hamasaki N; Izuhara K
Int Immunol; 2000 Nov; 12(11):1499-509. PubMed ID: 11058569
[TBL] [Abstract][Full Text] [Related]
7. Solution structure of human IL-13 and implication for receptor binding.
Moy FJ; Diblasio E; Wilhelm J; Powers R
J Mol Biol; 2001 Jun; 310(1):219-30. PubMed ID: 11419948
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain.
Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R
Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface.
Hage T; Sebald W; Reinemer P
Cell; 1999 Apr; 97(2):271-81. PubMed ID: 10219247
[TBL] [Abstract][Full Text] [Related]
10. IL-13 signal transduction in human monocytes: phosphorylation of receptor components, association with Jaks, and phosphorylation/activation of Stats.
Roy B; Bhattacharjee A; Xu B; Ford D; Maizel AL; Cathcart MK
J Leukoc Biol; 2002 Sep; 72(3):580-9. PubMed ID: 12223527
[TBL] [Abstract][Full Text] [Related]
11. Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts.
Lutz RA; Feng N; Moser R
J Recept Signal Transduct Res; 1999; 19(1-4):181-90. PubMed ID: 10071757
[TBL] [Abstract][Full Text] [Related]
12. A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Gauchat JF; Schlagenhauf E; Feng NP; Moser R; Yamage M; Jeannin P; Alouani S; Elson G; Notarangelo LD; Wells T; Eugster HP; Bonnefoy JY
Eur J Immunol; 1997 Apr; 27(4):971-8. PubMed ID: 9130652
[TBL] [Abstract][Full Text] [Related]
13. Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway.
Murata T; Husain SR; Mohri H; Puri RK
Int Immunol; 1998 Aug; 10(8):1103-10. PubMed ID: 9723696
[TBL] [Abstract][Full Text] [Related]
14. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
15. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Murata T; Taguchi J; Puri RK; Mohri H
Int J Hematol; 1999 Jan; 69(1):13-20. PubMed ID: 10641437
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
Arima K; Sato K; Tanaka G; Kanaji S; Terada T; Honjo E; Kuroki R; Matsuo Y; Izuhara K
J Biol Chem; 2005 Jul; 280(26):24915-22. PubMed ID: 15870068
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 and interleukin-13 signaling connections maps.
Kelly-Welch AE; Hanson EM; Boothby MR; Keegan AD
Science; 2003 Jun; 300(5625):1527-8. PubMed ID: 12791978
[TBL] [Abstract][Full Text] [Related]
18. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
19. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
20. A model of the ternary complex of interleukin-10 with its soluble receptors.
Pletnev S; Magracheva E; Wlodawer A; Zdanov A
BMC Struct Biol; 2005 Jun; 5():10. PubMed ID: 15985167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
